 for 24 weeks) was
associated with signiÔ¨Åcant improvements in pain-free and
maximal treadmill walking times and in measures of physical
function.98 Given the modest size of this trial (212 patients)
in three hospitals in Australia, further multicenter studies
with longer follow-up are needed to support the routine
use of ramipril for IC. This recommendation was stricken
post-publication by the guidelines committee based on
further review of the evidence